Genetic Technologies (AU:GTG) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Genetic Technologies Limited has successfully completed the sale of its geneType business and assets to Rhythm Biosciences, marking a significant move in the genomic diagnostics sector. The transaction, finalized on December 23, 2024, involves a seamless transition with the support of both companies. This development reflects ongoing shifts in the market as companies adapt and restructure towards innovative growth.
For further insights into AU:GTG stock, check out TipRanks’ Stock Analysis page.